clinical trial · NCT07387003
Evaluate the Efficacy and Safety of GZR101-80 Injection in Patients With Type 2 Diabetes
Type 2 Diabetes (T2DM)GZR101-80GZR33 or Insulin degludec/Insulin aspart or Insulin aspart30 (NovoRapid®30)
brief summary
This study will be conducted to evaluate the efficacy and safety of GZR101-80 Injection in patients with type 2 diabetes mellitus inadequately controlled on oral antidiabetic drugs or Basal Insulin.
started
Apr 10, 2026
primary completion
Feb 11, 2027
completion
Sep 23, 2027
last updated
Apr 15, 2026
official title
A Multicenter Phase 2 Clinical Study to Evaluate the Efficacy and Safety of GZR101-80 Injection in Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Oral Antidiabetic Drugs or Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol